Stretching increases how far joints move, at any age, for a modest weekly time investment, and is linked to more elastic arteries and slightly lower resting pressure. Injury protection, soreness relief and posture correction have not held up. Harms are uncommon. (Full Review)

Protocol

Standard static protocol

30-second holds

2–4 sets, 5–7 days weekly; 10 min/week per muscle group.

Contract-relax as the alternative method

Partner-assisted

Equals static; beats ballistic.

Conventional versus long-duration approaches

Up to 1 hour daily

Long duration targets strength and size.

Time to effect

Range of motion

3–4 weeks

Acute gains fade within 30 minutes.

Arterial stiffness

4–12 weeks

Reverses within 6 weeks of stopping.

Strength and muscle thickness

6 weeks or more

Requires high-volume protocols.

Benefits

High: Range of motion; arterial stiffness; endothelial function; blood pressure; walking speed in older adults; knee osteoarthritis pain; strength and muscle thickness

Medium: Lower all-cause and cardiovascular mortality; fewer night cramps; less plantar fasciitis pain

Low: Improved sleep quality; reduced depressive symptoms; lower blood glucose and glucose control

Speculative: Slowed tumour growth through a direct mechanical effect; increased muscle capillary density

Contraindications

Acute grade II–III muscle strain, under 6 weeks

Unhealed fracture or osteotomy at the joint

Dislocation, subluxation or instability, 12 weeks

Arthroplasty within 12 weeks, or outside limits

Loaded spinal flexion with T-score ≤ −2.5

End-range and inversions: vascular Ehlers-Danlos, Marfan, Loeys-Dietz

Hypermobility (Beighton ≥ 6), affected joints

Acute deep vein thrombosis or pulmonary embolism

Infection, arthritis flare, myositis ossificans

Key Interactions

Fluoroquinolones (ciprofloxacin): absolute caution

Corticosteroids (prednisone): caution

Anticoagulants (warfarin, apixaban): caution

Muscle relaxants, opioids (baclofen): caution

Statins (atorvastatin, simvastatin): monitor

Analgesics (ibuprofen, acetaminophen): monitor

Blood-pressure supplements (nitrate): additive

Resistance training: redundant and antagonistic

Collagen peptides with vitamin C: potentiating

Heat and foam rolling: potentiating

Risk & Side Effects

High: Acute loss of maximal strength

Medium: Musculoskeletal injury from unsupervised or extreme practice

Low: Transient heart rate and pressure rise during holds; instability if hypermobile; opportunity cost

Speculative: Nerve irritation from aggressive end-range stretching; excessive loss of tendon stiffness

Monitoring

Marker	Target	Why
Sit-and-reach	≥ 0 cm men, ≥ +5 cm women; +5 cm gain	Whole-chain posterior flexibility
Passive straight-leg raise	80–90°, side difference < 10°	Hamstring extensibility, nerve mobility
Shoulder back-scratch reach	Fingertips overlapping, gap ≤ 2 cm	Upper-limb flexibility
Ankle dorsiflexion lunge	≥ 10 cm, side diff < 1.5 cm	Constrains squat depth and gait
Sitting-rising test	≥ 8 of 10	Flexibility, strength, balance, mass
Resting blood pressure	110–120 / 70–75 mmHg	Primary cardiovascular endpoint
Resting heart rate	50–65 beats/min	Proxy for autonomic balance
Carotid–femoral pulse wave velocity	< 7.0 m/s under age 50; < 10 any age	Arterial-stiffness measure trials move
Beighton hypermobility score	0–3 of 9	Flags where added range adds risk

Cadence: Baseline, 4 and 12 weeks, then every 6–12 months; blood pressure monthly, pulse wave velocity annually.

Qualitative Assessment

Morning stiffness on rising: minutes before movement feels normal, recorded weekly
Ease of floor transfers: whether floor transfers need hand or knee support
Night cramp frequency: cramps per week
Post-session soreness: soreness beyond 48 hours signals excessive intensity
Perceived range in compound lifts: whether squat depth and overhead position feel free

Stretching for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment